Arvinas (ARVN) Cash from Operations (2017 - 2026)
Arvinas' (ARVN) quarterly Cash from Operations came in at 69200000.0 in Q1 2026, up 22.16% year-on-year from 56647145.49 in Q1 2025, and down 127.63% quarter-over-quarter from 30400000.0 in Q4 2025.
Arvinas (ARVN) Cash from Operations (2017 - 2026) Analysis & Trends
Arvinas' Cash from Operations history runs 10 years deep, the most recent figure standing at 69200000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 22.16% year-over-year to 69200000.0 in Q1 2026; TTM through Mar 2026 was 254100000.0, a 1.36% decrease from a year earlier, with the FY2025 full-year figure at 273800000.0, down 5.59% from the prior year.
- Cash from Operations fell to 69200000.0 in Q1 2026 per ARVN's latest filing, from 30400000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 50300000.0 in Q2 2024 and bottomed at 128000000.0 in Q3 2024.
- The 5-year median for Cash from Operations is 83100000.0 (2023), against an average of 71976470.59.
- Across the five-year window, Cash from Operations jumped 156.71% in 2024 and plunged 289.66% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 71200000.0 in 2022, then decreased by 16.71% to 83100000.0 in 2023, then decreased by 1.2% to 84100000.0 in 2024, then surged by 63.85% to 30400000.0 in 2025, then sank by 127.63% to 69200000.0 in 2026.
- Per Business Quant, the three latest ARVN Cash from Operations figures stand at 69200000.0 (Q1 2026), 30400000.0 (Q4 2025), and 59100000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | -69.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.20 Mn |
| Mar 31, 2026 | -69.20 Mn |
| Dec 31, 2025 | -30.40 Mn |
| Dec 31, 2025 | -30.40 Mn |
| Sep 30, 2025 | -59.10 Mn |
| Sep 30, 2025 | -59.10 Mn |
| Jun 30, 2025 | -95.40 Mn |
| Jun 30, 2025 | -95.40 Mn |
| Mar 31, 2025 | -88.90 Mn |
| Mar 31, 2025 | -88.90 Mn |
| Dec 31, 2024 | -84.10 Mn |
| Dec 31, 2024 | -84.10 Mn |
| Sep 30, 2024 | -128.00 Mn |
| Sep 30, 2024 | -128.00 Mn |
| Jun 30, 2024 | 50.30 Mn |
| Jun 30, 2024 | 50.30 Mn |
| Mar 31, 2024 | -97.50 Mn |
| Mar 31, 2024 | -97.50 Mn |
| Dec 31, 2023 | -83.10 Mn |
| Dec 31, 2023 | -83.10 Mn |